Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T126501 |
Xanthone V1a
|
||
Xanthone V1a 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T126501。 | |||
T11857 |
LIT-001
|
Oxytocin Receptor | Endocrinology/Hormones; GPCR/G Protein |
LIT-001 是非肽类催产素受体激动剂,EC50为55 nM,Ki 为226 nM。它可改善孤独症小鼠模型的社交互动。 | |||
T80160 |
ω-Hexatoxin-Hv1a
ω-ACTX-Hv1,ω-Atracotoxin-HV1 |
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
ω-Hexatoxin-Hv1a,一种从毒液蜘蛛 (Hadronyche versuta) 分离得到的神经毒素,能够阻断电压门控钙通道 (calcium channels)。 | |||
T6453 |
Conivaptan hydrochloride
Vaprisol,盐酸考尼伐坦,Conivaptan HCl,YM 087 |
Vasopressin Receptor | GPCR/G Protein |
Conivaptan hydrochloride (Vaprisol) 是一种口服有效的加压素 V2 和 V1A 受体拮抗剂,用于治疗高血容量性低钠血症和正常血容量。 | |||
T4141 |
RG7713
RO 5028442 |
Vasopressin Receptor | GPCR/G Protein |
RG7713 (RO 5028442) 是一种高效且有选择性的脑-渗透加压素 1a (V1a) 受体拮抗剂,对人类 (hV1a) 和小鼠 (mV1a) 受体的 Ki 值分别为 1 和 39 nM,可用于研究自闭症的试验。 | |||
TP2082L |
d[Cha4]-AVP acetate(500170-27-4 free base)
|
Vasopressin Receptor | GPCR/G Protein |
d[Cha4]-AVP acetate(500170-27-4 free base) 是一种有效的选择性人血管加压素 V1B 受体激动剂(V1B、V1A、催产素和 V2 受体的 Ki 值分别为 1.2、151、240 和 750 nM)。刺激 ACTH 和皮质酮分泌,并在体内表现出微不足道的血管加压活性。 | |||
T14494 |
Balovaptan
RG7314 |
Vasopressin Receptor | GPCR/G Protein |
Balovaptan (RG7314) 是一种高效和选择性的脑渗透性血管加压素 1a (hV1a) 受体拮抗剂,对人类 (hV1a) 和小鼠 (mV1a) 受体的 Ki 值分别为 1 和 39 nM,可用于自闭症的研究。 | |||
T16934 |
SRX246
|
Others | Others |
SRX246 has no interaction at V1b and V2 receptors. SRX246 shows negligible binding at 64 other receptors classes, including 35 G-proteincoupled receptors. SRX246 is a potent and CNS-penetrant vasopressin 1a (V1a) receptor antagonist (Ki=0.3 nM for human V | |||
T28629 |
RWJ 676070
RWJ676070,RWJ-676070 |
||
RWJ 676070 is an antagonist of vasopressin V1A/V2 receptor. | |||
T24625 |
PF-184563
PF184563,PF 184563 |
||
PF-184563 is an effective and selective non-peptidic V1a receptor antagonist. | |||
T28745 |
Selepressin
FE 202158,FE202158 |
||
Selepressin, an analog of vasopressin, is a potent, selective vasopressin V1a receptor agonist. | |||
T17251 |
VNA-932
WAY-VNA 932 |
Others | Others |
VNA-932 is an agonist of the vasopressin V2-receptor (IC50: 80.3 nM and 778 nM in human-V2 binding and V1a binding assay). | |||
T28854 |
SRX 251
SRX-251,SRX251 |
||
SRX 251, a vasopressin V1a receptor antagonist, is used potentially for the treatment of primary dysmenorrhea. | |||
T29177 |
YM 218
YM218,YM-218 |
||
YM 218 is a novel, potent, selective antagonist of nonpeptide vasopressin V1A receptor. | |||
T23393 |
SR 49059
|
Others | Others |
vasopressin V1A receptor antagonist | |||
T80137 |
(d(CH2)51,Tyr(Me)2,Dab5,Arg8)-Vasopressin
d(CH2)5[Tyr(Me)2, Dab5]AVP |
Vasopressin Receptor | GPCR/G Protein |
(d(CH2)51,Tyr(Me)2,Dab5,Arg8)-Vasopressin (d(CH2)5[Tyr(Me)2, Dab5]AVP)作为针对加压素受体V1a的特异性拮抗剂,具有pA2值为6.71。 | |||
T15682 |
L-371,257
|
Oxytocin Receptor; Vasopressin Receptor | Endocrinology/Hormones; GPCR/G Protein |
L-371,257 是催产素受体的竞争性拮抗剂,pA2 为 8.4,Ki 为 19 nM。 L-371,257 对加压素受体 1a 的 Ki 值为 3.7 nM。 | |||
T25577 |
Khusimol
|
||
Khusimol is a vasopressin V1a receptors non-peptide ligand that acts by inhibiting the binding of vasopressin. | |||
T29178 |
YM 471
YM-471,YM471 |
||
YM 471 is a non-peptide arginine vasopressin (AVP) V1A and V2 receptor antagonist with oral activity. | |||
TP2136 |
(d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin
|
||
Selective vasopressin V1A receptor antagonist. Inhibits vasopressin and oxytocin-induced increases in intracellular calcium concentrations in vitro (IC50 values are 5 and 30 nM respectively). Exhibits potent and prolonged antivasopressor activity and indu | |||
T24370 |
L-368899 free base
L 368899,L 368,899,L368,899,L-368899,L368899,L-368,899 |
||
L-368899 is a non-peptide and orally active antagonist of oxytocin receptor (IC50: 8.9 nM). It displays 40-fold selectivity over vasopressin V1a and V2 receptors (IC50: 370 and 570 nM respectively). | |||
T80270 |
Invopressin
OCE-205 |
Vasopressin Receptor | GPCR/G Protein |
Invopressin (Compound 42),一种vasopressin V1A 受体部分激动剂(EC50: 1.0 nM),主要应用于肝硬化相关症状如细菌性腹膜炎、HRS2 及难治性腹水的研究。 | |||
TP1927 |
d[Leu4,Lys8]-VP
|
||
Selective vasopressin V1B receptor agonist (Ki values are 0.16, 64, 100 and 3800 nM for V1B, oxytocin, V2 and V1A receptors respectively). Displays weak antidiuretic, vasopressor and in vitro oxytocic activities. | |||
T80136 |
Val9-Oxytocin
|
Vasopressin Receptor | GPCR/G Protein |
Val9-Oxytocin为完全抗拮抗加压素(1a)受体的化合物,其结构上是Oxytocin的衍生物,特点在于Gly9位点被Val9取代。 | |||
TP2082 |
d[Cha4]-AVP
|
||
Potent and selective human vasopressin V1B receptor agonist (Ki values are 1.2, 151, 240 and 750 nM for V1B, V1A, Oxytocin and V2 receptors respectively). Stimulates ACTH and corticosterone secretion and exhibits negligible vasopressor activity in vivo. | |||
T75933 |
d[Cha4]-AVP TFA
|
||
d[Cha4]-AVP TFA 是一种有效的选择性加压素 (AVP)V1b 受体激动剂,对人V1b 受体的Ki 为 1.2 nM。d[Cha4]-AVP TFA 对 V1b 受体的选择性高于对人类 V1a 受体、V2 受体和催产素受体。 | |||
T21378 |
Conivaptan
YM087,YM-087,YM 087,Vaprisol |
||
Conivaptan, a non-peptide inhibitor of antidiuretic hormone, was approved for hyponatremia caused by the syndrome of inappropriate antidiuretic hormone (SIADH), there is also some evidence that it may be effective in heart failure. Conivaptan inhibits sub | |||
T75708 |
Argipressin diacetate
|
||
Argipressin (diacetate) (AVP (diacetate),又称antidiuretic hormone (ADH)) 是一种由垂体后叶分泌的含9个氨基酸的神经肽。通过作用于三种G蛋白偶联受体(GPCRs),Avpr1a (V1a)、Avpr1b (V1b) 及Avpr2 (V2),它调控体液平衡、渗透压及心血管系统的生理功能,并可能对中枢代谢过程产生重要影响。 | |||
T73654 |
Selepressin acetate
|
||
Selepressin (FE 202158) acetate 是一种选择性的加压素 V1A 受体 (vasopressin V1Areceptor) 激动剂。Selepressin acetate 是一种有效的血管加压素。Selepressin acetate 可用于脓毒性休克的研究。 | |||
T28257 |
OPC-51803
SOU-003,SOU 003,SOU003,OPC51803,OPC 51803 |
Vasopressin Receptor | GPCR/G Protein |
OPC-51803是一种可口服的非肽加压素(AVP)V(2)受体选择性激动剂,可用于治疗尿失禁和夜尿。 |